批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/09/29 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM 剂型/给药途径:TABLET;ORAL 规格:12.5MG;50MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020387 |
001 |
NDA |
HYZAAR |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Prescription |
Yes |
No |
AB |
1995/04/28
|
ORGANON |
077157 |
001 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Prescription |
No |
No |
AB |
2010/04/06
|
TEVA PHARMS |
077948 |
001 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Prescription |
No |
No |
AB |
2010/10/06
|
SANDOZ |
078245 |
001 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Prescription |
No |
No |
AB |
2010/10/06
|
LUPIN LTD |
078385 |
001 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Prescription |
No |
No |
AB |
2010/10/06
|
ZYDUS PHARMS USA INC |
091629 |
001 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Prescription |
No |
No |
AB |
2010/10/06
|
AUROBINDO PHARMA |
091617 |
001 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Prescription |
No |
No |
AB |
2012/02/17
|
ALEMBIC PHARMS LTD |
202289 |
001 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Prescription |
No |
No |
AB |
2012/08/09
|
MACLEODS PHARMS LTD |
201845 |
001 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Prescription |
No |
No |
AB |
2012/09/18
|
JUBILANT CADISTA |
201682 |
001 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Prescription |
No |
No |
AB |
2013/03/01
|
IPCA LABS LTD |
204832 |
001 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Prescription |
No |
No |
AB |
2017/07/21
|
UNICHEM |
204901 |
001 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Prescription |
No |
No |
AB |
2017/11/06
|
PRINSTON INC |
218015 |
001 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;50MG |
Discontinued |
No |
No |
AB |
2023/09/29
|
GRANULES |
活性成分:HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM 剂型/给药途径:TABLET;ORAL 规格:12.5MG;100MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020387 |
003 |
NDA |
HYZAAR |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;100MG |
Prescription |
Yes |
No |
AB |
2005/10/20
|
ORGANON |
077157 |
002 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;100MG |
Prescription |
No |
No |
AB |
2010/04/06
|
TEVA PHARMS |
078245 |
002 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;100MG |
Prescription |
No |
No |
AB |
2010/05/21
|
LUPIN LTD |
077948 |
003 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;100MG |
Prescription |
No |
No |
AB |
2010/08/19
|
SANDOZ |
091629 |
002 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;100MG |
Prescription |
No |
No |
AB |
2010/10/06
|
AUROBINDO PHARMA |
091617 |
002 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;100MG |
Prescription |
No |
No |
AB |
2012/02/17
|
ALEMBIC PHARMS LTD |
202289 |
002 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;100MG |
Prescription |
No |
No |
AB |
2012/08/09
|
MACLEODS PHARMS LTD |
201845 |
002 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;100MG |
Prescription |
No |
No |
AB |
2012/09/18
|
JUBILANT CADISTA |
201682 |
002 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;100MG |
Prescription |
No |
No |
AB |
2013/03/01
|
IPCA LABS LTD |
204832 |
002 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;100MG |
Prescription |
No |
No |
AB |
2017/07/21
|
UNICHEM |
204901 |
002 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;100MG |
Prescription |
No |
No |
AB |
2017/11/06
|
PRINSTON INC |
218015 |
002 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
12.5MG;100MG |
Discontinued |
No |
No |
AB |
2023/09/29
|
GRANULES |
活性成分:HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM 剂型/给药途径:TABLET;ORAL 规格:25MG;100MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020387 |
002 |
NDA |
HYZAAR |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Prescription |
Yes |
No |
AB |
1998/11/10
|
ORGANON |
091629 |
003 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Prescription |
No |
Yes |
AB |
2010/01/06
|
AUROBINDO PHARMA |
077157 |
003 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Prescription |
No |
No |
AB |
2010/04/06
|
TEVA PHARMS |
077948 |
002 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Prescription |
No |
No |
AB |
2010/10/06
|
SANDOZ |
078245 |
003 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Prescription |
No |
No |
AB |
2010/10/06
|
LUPIN LTD |
078385 |
002 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Prescription |
No |
No |
AB |
2010/10/06
|
ZYDUS PHARMS USA INC |
091617 |
003 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Prescription |
No |
No |
AB |
2012/02/17
|
ALEMBIC PHARMS LTD |
202289 |
003 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Prescription |
No |
No |
AB |
2012/08/09
|
MACLEODS PHARMS LTD |
201845 |
003 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Prescription |
No |
No |
AB |
2012/09/18
|
JUBILANT CADISTA |
201682 |
003 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Prescription |
No |
No |
AB |
2013/03/01
|
IPCA LABS LTD |
204832 |
003 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Prescription |
No |
No |
AB |
2017/07/21
|
UNICHEM |
204901 |
003 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Prescription |
No |
No |
AB |
2017/11/06
|
PRINSTON INC |
218015 |
003 |
ANDA |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TABLET;ORAL |
25MG;100MG |
Discontinued |
No |
No |
AB |
2023/09/29
|
GRANULES |